Hemoptysis

Diagnosis

• Past history, history of present illness, family history
  • history of tuberculosis, bronchiectasis, chronic bronchitis, mitral stenosis, etc.
  • history of cigarette smoking, occupational diseases by exposure to silica dust, etc.
• Blood
  • duration, frequency, amount
  • Amounts of blood: large amounts of blood, or there is blood-streaked sputum
  • Probable source of bleeding: Is the blood coughed up, or vomited?
• Bloody sputum
  • color, characters: blood-streaked, fresh blood, frothy pink, bloody gelatinous.
• Accompanying symptoms
  • fever, chest pain, coughing, purulent sputum, mucocutaneous bleeding, jaundice.
• Imaging examination
  • chest X-ray, CT scan and 3D reconstruction images or CT virtual bronchoscopy, bronchial angiography.
• Laboratory tests
  • blood test: WBC
  • Sputum: cells and bacterial examinations, sputum culture
• Bronchial fiber endoscopy

Differential diagnosis

The most common causes for hemoptysis in adults are chest infections such as bronchitis or pneumonia. In children, hemoptysis is commonly caused by the presence of a foreign body in the airway. Other common causes include lung cancers and tuberculosis. Less common causes include aspergilloma, bronchiectasis, coccidioidomycosis, pulmonary embolism, pneumonic plague, and cystic fibrosis. Rarer causes include hereditary hemorrhagic telangiectasia (HHT or Rendu-Osler-Weber syndrome), Goodpasture's syndrome, and granulomatosis with polyangiitis. A rare cause of hemoptysis in women is endometriosis, which leads to intermittent hemoptysis coinciding with menstrual periods in 7% of women with thoracic endometriosis syndrome. Hemoptysis may be exacerbated or even caused by overtreatment with anticoagulant drugs such as warfarin.

Blood-laced mucus from the sinus or nose area can sometimes be misidentified as symptomatic of hemoptysis (such secretions can be a sign of nasal or sinus cancer, but also a sinus infection). Extensive non-respiratory injury can also cause one to cough up blood. Cardiac causes like congestive heart failure and mitral stenosis should be ruled out. The origin of blood can be identified by observing its color. Bright-red, foamy blood comes from the respiratory tract, whereas dark-red, coffee-colored blood comes from the gastrointestinal tract. Sometimes hemoptysis may be rust-colored.

• Lung cancer, including both non-small cell lung carcinoma and small cell lung carcinoma.
• Sarcoidosis
• Aspergilloma
• Tuberculosis
• Histoplasmosis
• Pneumonia
• Pulmonary edema
• Endometriosis and thoracic endometriosis syndrome{{cite web |url=https://www.lecturio.com/concepts/endometriosis/| title=Endometriosis
• Foreign body aspiration and aspiration pneumonia{{cite web |url=https://www.lecturio.com/concepts/foreign-body-aspiration/| title=Foreign Body Aspiration
• Goodpasture's syndrome
• Microscopic polyangiitis
• Granulomatosis with polyangiitis
• Eosinophilic granulomatosis with polyangiitis
• Bronchitis
• Bronchiectasis
• Pulmonary embolism
• Anticoagulant use
• Trauma
• Lung abscess
• Mitral stenosis{{cite web |url=https://www.lecturio.com/concepts/mitral-stenosis/| title=Mitral Stenosis
• Tropical pulmonary eosinophilia
• Bleeding disorders
• Hughes-Stovin syndrome and other variants of Behçet's disease
• Pulmonary arteriovenous malformations

Massive hemoptysis and mortality

Although there are reports that the fatality rate is as high as 80%, the mortality rate for hospitalized hemoptysis patients is 9.4% (with n=28539), calculated from the data in the article by Kinoshita et al. This is probably the most reasonable figure considering the overwhelming number of cases.

The general definition of massive hemoptysis is more than 200 ml within 24 hours, but there is a wide range in the literature (100–600 ml). Considering that the total volume of the tracheal and bronchial lumen is about 150 cc, it may be reasonable to define massive hemoptysis as 200 ml, which is a little more than 150 ml, in terms of setting the threshold for fatal hemoptysis. More than 400ml/day is not adequate for screening purposes.

Treatment

Treatment depends on the underlying cause. Treatments include iced saline, and topical vasoconstrictors such as adrenaline or vasopressin. Tranexamic acid was proved to improve in-hospital mortality. Selective bronchial intubation can be used to collapse the lung that is bleeding. Also, endobronchial tamponade can be used. Laser photocoagulation can be used to stop bleeding during bronchoscopy. Angiography of bronchial arteries can be performed to locate the bleeding, and it can often be embolized. Bronchial artery embolization (BAE) is the first line treatment nowadays. Surgical option is usually the last resort and can involve removal of a lung lobe or removal of the entire lung. Cough suppressants can increase the risk of choking.

References

References

1. (2014). "Pocket medicine". Aspen Publishers, Inc.
2. "Hemoptysis".
3. Richard F.LeBlond. (2004). "Diagnostics". McGraw-Hill Companies, Inc..
4. (September 2020). "Thoracic endometriosis presenting as a catamenial hemothorax with discordant video-assisted thoracoscopic surgery". Radiology Case Reports.
5. [https://health.google.com/health/ref/Lung+cancer+-+small+cell Google Health – Google]
6. [https://health.google.com/health/ref/Lung+cancer+-+non-small+cell Google Health – Google]
7. "Sarcoidosis Signs & Symptoms – Sarcoidosis – HealthCommunities.com".
8. {{MedlinePlusEncyclopedia. 000127. Pulmonary aspergilloma
9. [https://health.google.com/health/ref/Pulmonary+tuberculosis Google Health – Google]
10. "Histoplasmosis Symptoms – Diseases and Conditions – Mayo Clinic".
11. (27 August 2020). "Pneumonia".
12. (2 May 2011). "Dorland's illustrated medical dictionary". Saunders/Elsevier.
13. (December 2005). "Clinical practice. Acute pulmonary edema". N. Engl. J. Med..
14. {{EMedicine. article. 1001872. Pediatric Goodpasture Syndrome
15. (March 2005). "Microscopic polyangitis presenting with sub-acute reversible optic neuropathy". Eye (Lond).
16. "Granulomatosis with Polyangiitis". Mayo Foundation for Medical Education and Research.
17. "Eosinophilic Granulomatosis with Polyangiitis (EGPA)". Merck & Co.
18. "Hemoptysis Causes – Hemoptysis – HealthCommunities.com".
19. "Other Causes of Hemoptysis – Hemoptysis – HealthCommunities.com".
20. (2020). "Tropical Pulmonary Eosinophilia". StatPearls Publishing.
21. (2014). "Bleeding and Coagulopathies in Critical Care". New England Journal of Medicine.
22. (January 1959). "Segmental pulmonary artery aneurysms with peripheral venous thrombosis.". British Journal of Diseases of the Chest.
23. (November 2019). "Effect of tranexamic acid on mortality in patients with haemoptysis: a nationwide study". Critical Care.
24. (September 2015). "Anatomy and physiology of respiratory system relevant to anaesthesia". Indian Journal of Anaesthesia.
25. (January 2020). "Managing Massive Hemoptysis". Chest.
26. (June 2005). "Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis". Chest.
27. (August 2004). "Guidelines for treatment of acute lung diseases.". Uppsala Academic Hospital.
28. (November 2013). "Bronchial artery embolization to control hemoptysis: comparison of N-butyl-2-cyanoacrylate and polyvinyl alcohol particles". Radiology.
29. (February 2017). "Efficacy and safety of super selective bronchial artery coil embolisation for haemoptysis: a single-centre retrospective observational study". BMJ Open.
30. (February 2019). "Mechanisms of recurrent haemoptysis after super-selective bronchial artery coil embolisation: a single-centre retrospective observational study". European Radiology.
31. (2017-07-07). "Bronchial artery embolization in hemoptysis: a systematic review". Diagnostic and Interventional Radiology.
32. (May 2020). "ACR Appropriateness Criteria® Hemoptysis". Journal of the American College of Radiology.